Qiagen N.V. Common Shares (QGEN)

R&D Expenses

$194.67M

TTM · Period ending: · USD

QGEN logo

QGEN R&D Expenses

Latest reported$194.67M
QGEN TTM R&D Expenses ($1.30M → $194.67M)
High-resolution chart · PNG

QGEN r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Qiagen N.V. Common Shares R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
25,054,000
23,691,000
21,341,000
20,197,000
18,565,000
16,890,000
16,278,000
15,187,000
14,700,000
13,600,000
12,500,000
11,100,000
9,800,000
9,000,000
8,300,000
6,000,000
4,000,000
1,900,000
1,300,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.